Cognivue

Cognivue

Medical Devices, 7911 Rae BLVD, Victor, New York, 14564, United States, 11-50 Employees

cognivue.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 15*********

Who is COGNIVUE

Cognivue is a risk assessment test that identifies changes in cognitive function that could be indicative of early dementia or Alzheimer's Disease. It is the world's first FDA-Cleared com...

Read More

map
  • 7911 Rae BLVD, Victor, New York, 14564, United States Headquarters: 7911 Rae BLVD, Victor, New York, 14564, United States
  • 2018 Date Founded: 2018
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $10 Million to $25 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Medical Devices

SIC SIC Code: 3674 | NAICS Code: 541690 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from COGNIVUE

Cognivue Org Chart and Mapping

Employees

Similar Companies to Cognivue

Ceek Women's Health

  • 11-50 11-50
  • 5 Million to 10 Million $ 5 Million to 10 Million

Cochlear

  • 201-500 201-500
  • 5 Million to 10 Million $ 5 Million to 10 Million

Global Alzheimer's Platform Foundation

  • 11-50 11-50
  • 250 Million to 500 Million $ 250 Million to 500 Million
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Cognivue

Answer: Cognivue's headquarters are located at 7911 Rae BLVD, Victor, New York, 14564, United States

Answer: Cognivue's phone number is 15*********

Answer: Cognivue's official website is https://cognivue.com

Answer: Cognivue's revenue is $10 Million to $25 Million

Answer: Cognivue's SIC: 3674

Answer: Cognivue's NAICS: 541690

Answer: Cognivue has 11-50 employees

Answer: Cognivue is in Medical Devices

Answer: Cognivue top competitors include: Ceek Women's Health , Cochlear , Global Alzheimer's Platform Foundation

Answer: Cognivue contact info: Phone number: 15********* Website: https://cognivue.com

Answer: Cognivue is a risk assessment test that identifies changes in cognitive function that could be indicative of early dementia or Alzheimer's Disease. It is the world's first FDA-Cleared computerized test of cognitive function. Cognivue was designed to objectively, quantitatively and reliably identify changes in cognitive function that could be indicative of early dementia or Alzheimer's Disease. It allows clinicians the opportunity to establish a baseline cognitive score that can be monitored over time. Cognivue measures and monitors cognitive health by testing 4 key cognitive domains. This 10 minute test measures tracking movement, vision, perception and memory of letters, words, shapes and motion. Unlike paper and pencil cognitive testing, Cognivue is based on neurophysiology and psychophysical research. Upon completion of the test, Cognivue immediately creates a report with a clinical risk score of cognitive health. Using the patient's risk score, you will be able to determine the patient's risk stratification and proper course of action to improve patient care.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access